The UK's MHRA has revoked the marketing approval for Valneva's chikungunya vaccine, Ixchiq, due to unfavorable benefit-risk ...

Zydus Lifesciences initiates a Class II recall of Hydrocortisone Sodium Succinate in the US due to impurity and degradation ...

CSL, Australia's leading biotechnology company, has appointed Deborah Waterhouse as its new CEO, marking a significant ...

Explore how cheap Chinese antibiotics threaten the survival of Europe's final major penicillin manufacturing facility in ...

Danaher's CEO highlights the company's strategic position to lead in AI-driven drug discovery, with plans for an AI-powered ...

Alkem Laboratories embarks on a forensic audit to investigate alleged fund misappropriation by a former employee, appointing ...

Abbott Laboratories has announced plans to spin off its nutrition business while cutting its 2026 sales growth forecast amid ...

AstraZeneca announces FDA accelerated approval for Ultomiris, a groundbreaking treatment for immunoglobulin A nephropathy, a ...

China's Hansoh Pharmaceutical has partnered with Roche in a groundbreaking licensing deal worth over $15 billion, focusing on ...

Zydus Lifesciences announced FDA approval for Estradiol and Levonorgestrel Transdermal System for menopause treatment, ...

The US FDA approves GSK's Hibsago for chronic hepatitis B, providing patients a chance to control the virus post-treatment.

Dr Reddy's Laboratories receives regulatory approval to use Zytorvi as a first-line treatment for advanced esophageal ...